# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Noonan Syndrome
- **MONDO ID:**  (if available)
- **Category:** Genetic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Noonan Syndrome**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-02-02T12:45:44.823534

1. cuevasnavarro2023rasdependentrafmapkhyperactivation pages 1-2
2. abe2024dysregulationofras pages 1-2
3. brouchoven2025trametinibasa pages 2-3
4. faienza2024cardiacphenotypeand pages 10-11
5. saintlaurent2024noveltherapeuticperspectives pages 1-2
6. reynolds2025updateonthe pages 20-21
7. pascarella2024refractorychylothoraxand pages 1-2
8. gazzin2024exploringnewdrug pages 1-2
9. yi2023anassessmentof pages 3-4
10. pascarella2024refractorychylothoraxand pages 6-7
11. faienza2024cardiacphenotypeand pages 1-2
12. reynolds2025updateonthe pages 17-18
13. pascarella2024refractorychylothoraxand pages 11-12
14. pascarella2024refractorychylothoraxand pages 12-13
15. https://doi.org/10.1126/sciadv.adf4766
16. https://doi.org/10.1172/jci.insight.182382
17. https://doi.org/10.1172/jci172839
18. https://doi.org/10.3390/life14060731;
19. https://doi.org/10.1007/s00431-023-05263-y
20. https://doi.org/10.3390/children11111342
21. https://doi.org/10.1016/j.jacc.2019.01.066
22. https://doi.org/10.1158/1078-0432.ccr-24-1611
23. https://doi.org/10.3390/life14060731
24. https://doi.org/10.3390/genes15081015
25. https://doi.org/10.1007/s10557-022-07324-0
26. https://doi.org/10.1007/s00431-023-05263-y,
27. https://doi.org/10.3390/ijms26083515,
28. https://doi.org/10.3390/genes15081015,
29. https://doi.org/10.3390/ijms26083515
30. https://doi.org/10.1007/s10557-022-07324-0,
31. https://doi.org/10.1126/sciadv.adf4766,
32. https://doi.org/10.1172/jci.insight.182382,
33. https://doi.org/10.3389/fped.2025.1475143,
34. https://doi.org/10.3390/children11111342,
35. https://doi.org/10.3390/life14060731,